Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...
Company to host conference call and webcast today at 4:30 PM ETNASHUA, N.H., May 11, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer ...
iCAD signs strategic multi-year commercial agreement with Radiology Partners, the nation’s largest radiology practice providing 15% of all U.S. mammography screenings, through its owned and affiliated ...
A new set of real-world data from the 3D mammogram developer iCAD showed that its artificial intelligence-powered screening programs were able to increase breast cancer detection rates and help cut ...
Google’s health division has expanded its agreement to integrate its artificial intelligence technology into medtech company iCAD’s 2D mammography suite, about nine months after the tech giant first ...
Icad Inc ICAD shares are trading higher Monday after the company announced a strategic development and commercialization agreement with Alphabet Inc's GOOG Google Health. The agreement will allow ...
NASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C., July 29, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today announced ...
NASHUA, N.H.--(BUSINESS WIRE)-- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment ...
(MENAFN- GlobeNewsWire - Nasdaq) NASHUA, N.H., July 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the“Company”), a global leader in clinically proven AI-powered cancer detection ...
Groundbreaking ProFound AI Risk Helps Transform Breast Cancer Screening from an Age-Based Paradigm to Risk-Adapted Precision Screening, Individualized for Each Woman NASHUA, N.H., Nov. 30, 2020 (GLOBE ...
Google Health will use its artificial intelligence tools to detect breast cancer through a new integration with medtech company iCad. The AI technology will be used within iCad’s Profound Breast ...
icad (ICAD) is scheduled to report earnings on March 11, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results